Section 100 could be applied to other life‑saving drugs, says Kerala High Court

Justice Menon warned that if the need arises, the government may invoke Section 100 not only for the present breast‑cancer medicines but also for other essential drugs that are priced beyond the reach of patients. The ruling emphasizes a broader view of the provision as a tool for public health emergencies, pending a thorough cost‑benefit analysis.